The aim of this study was to determine the prevalence and clinical characteristics of epilepsy and seizure disorders in Bradford.
Epilepsy is the most common serious neurological condition 1 . Epidemiological data are important not only to improve our understanding about the condition and its aetiology, but also to allow a rational approach to planning health services which meet health needs 2 .
We undertook a community-based study to determine the prevalence of epilepsy and seizure disorders in Bradford.
MATERIALS AND METHODS
The study was undertaken between 1996 and 1998 in an urban primary care setting in Bradford, England. Bradford is a manufacturing city with a large South Asian † population and comparatively high indices of deprivation. There are 83 general practices covering a population of 360 000. The South Asian population comprises 87 300 people (24% of the population), of whom 80% are of Pakistani origin. All practices were invited to participate in the study. Case ascertainment was by review of the medical records. Cases were identified using two methods: (1) searching of computerized practice databases using all diagnostic terms and codes for epilepsy and seizure disorders; (2) searching of prescribing data for 12 anticonvulsant drugs (carbamazepine, sodium valproate, phenytoin, phenobarbitone, lamotrigine, clobazam, primidone, gabapentin, clonazepam, vigabatrin, topiramate, ethosuximide).
A specialist epilepsy nurse then reviewed the medical records of all cases identified, consulting with the † South Asians refers to people who were born in or originate from the Indian subcontinent. general practitioner when necessary to clarify details.
Information was recorded on a data extraction form. Where there was doubt over the diagnosis or treatment, or where there was only limited information available in the records, the patient was invited for review by a neurologist in an epilepsy clinic. Internationally agreed case definitions were used to classify categories of epilepsy and seizure type 3 .
The following information was collected: demographic details; seizure type and frequency; medication; aetiology and co-morbidity.
Analysis
Collation of data and descriptive analysis was undertaken using Access software. South Asian ethnicity was identified using Nam Pehchan, a validated software programme used to identify South Asian names and their religious and linguistic origin, and manual checks of patients' names.
Prevalence was calculated as a point prevalence at the end of the ascertainment period with patients considered prevalent if they were alive and resident in the district on 1st November 1998. Direct standardization of prevalence rates was carried out using the European Standard population. Confidence intervals were calculated using Confidence Interval Analysis software, but not for prevalence rates as we were not considering a randomly selected sample. Case ascertainment is the main potential source of bias in our study.
RESULTS
Thirty-nine practices (47%) agreed to participate, covering a population of 225 439 (63% of the total population). There was a lower proportion of inner-city primary care group practices (36% vs. 66%, OR 0.30, 95% CI 0.12, 0.71) in participating practices. Innercity practices tended to cover smaller practice populations (70% under 5000 population list size) and 50% were single-handed general practitioners.
Prevalence
There were 1991 possible cases identified from searches of the medical records. Of these, 542 (27.2%) patients were invited for review by the neurologist because of diagnostic uncertainty or lack of information in the records; 382 (70.5%) of these patients attended the epilepsy clinic and 152 (7.6%) cases were found not to have a diagnosis of epilepsy. For 122 (6.1%) patients the diagnosis of epilepsy was doubtful and non-epileptic events considered responsible and 74 (3.7%) patients were diagnosed as having had a single seizure.
In 1643 (84%) of cases a diagnosis of epilepsy was either confirmed by record review or neurological assessment (prevalence 7.3/1000). Classification of patients by internationally agreed definitions showed 1013 (62%) of cases with active epilepsy (prevalence 4.5/1000); 421 (26%) with epilepsy in remission on treatment and 209 (13%) with epilepsy in remission off treatment.
Information about the type of seizure was recorded in the medical records or obtained at review for 1561 (95.0%) patients (Table 1) ; 156 (17.8%) patients had two seizure types recorded, and 22 (3.0%) had three seizure types.
In addition, 1140 (69.4%) of cases had been investigated by EEG, 693 (42.2%) had undergone a CT scan and 55 (3.4%) an MRI.
Demography
Eight hundred and thirty-one (51.1%) of cases were male and 101 (6.2%) of cases were of South Asian origin. Figure 1 shows the age standardized rates by ethnicity. The standardized rate for all patients of South Asian origin was 3.6/1000 compared to 7.8/1000 in the rest of the population (OR 0.46; 95% CI 0.38, 0.57). Table 2 shows the aetiology of epilepsy. Cerebrovascular disease and head injuries were the commonest causes identified. Two hundred and seventy-three (16.6%) of cases had learning disabilities although the relationship with epilepsy and congenital or perinatal aetiological factors could not be determined from recorded information.
Aetiology
Two hundred and twenty-seven (13.8%) of cases had a family history (first degree relatives) of epilepsy.
Treatment
Of those patients currently on treatment with anticonvulsant drugs, 1109 (69.5%) were on single drug treatment, 389 (24.4%) were taking two, 81 (5.1%) three, and 16 (1%) four anticonvulsant drugs. Table 3 shows the frequency of anticonvulsant drug prescribing.
DISCUSSION
This community-based study is one of the largest epidemiological studies of epilepsy undertaken in the Prevalence of epilepsy in Bradford (Odds ratios, 95% confidence intervals) United Kingdom. Three types of bias are important to consider for a study that relied predominantly on medical records as a source of case ascertainment and information: recruitment, case ascertainment and recording.
There was an under-representation of inner-city primary care group practices recruited. These are commonly single-handed, small practices where limited research access might be anticipated. This underrepresentation is particularly important when considering the validity of the results of the effect of ethnicity on prevalence. The majority (89%) of patients of South Asian origin are registered in these practices. However, 77% of South Asian patients included in this study came from the inner-city primary care group and there is no reason to expect that they are different from the total South Asian population in Bradford.
Case ascertainment was through searching records by diagnostic codes and prescribing information. Limitations in the recording of diagnostic terms and codes, particularly in patients with epilepsy in remission off treatment, are likely to have led to underascertainment of these patients. However, the use of prescribing information will have provided accurate prevalence rates for patients with active epilepsy and epilepsy in remission on treatment.
Recording bias was minimized by having a trained epilepsy nurse to abstract information and expert review from a neurologist in cases where there was uncertainty. Under-recording of clinical information such as aetiology and family history in medical records may reduce the validity of these data. Ideally in an epidemiological study of epilepsy, all cases would have been interviewed to confirm the diagno- sis and risk factors. This was not practical in such a large study. However nearly one quarter of patients were reviewed by a neurologist and these were the cases where there was limited information in the medical records.
Prevalence
Previous studies have reported a wide range of prevalence rates for epilepsy 1, 4 . Much of this variation will be due to problems with diagnosis and case ascertainment in the different methods used, and variation in definitions adopted. Our prevalence rate of 4.5/1000 for active epilepsy and 6.3/1000 for treated epilepsy is in line with previous estimates from the United Kingdom which range from 4.2-5.3/1000 [5] [6] [7] [8] . Age standardized rates demonstrate increasing prevalence with increasing age, supporting previous findings 4, 8 . Nearly 10% of patients on anticonvulsant drugs had a diagnosis of epilepsy refuted either because of nonepileptic events or single seizures. Although the clinical review provided the opportunity to stop treatment, very few patients have agreed, either because of anxiety over occurrence of seizures after withdrawal, or from habit. Research is being undertaken to explore this finding further.
One unexpected result was the low prevalence of epilepsy in the South Asian population. A number of possible explanations exist for the low prevalence observed in the South Asian population. The difference may be real. However this is not supported from other studies 9 , and has little biological plausibility, particularly in view of the higher incidence of cerebrovascular disease in South Asians. The difference may be due to selective migration. The majority of South Asians over 25 years were born outside the UK 10 and this might explain the lower prevalence observed in the older age groups. However it does not explain the differences (albeit smaller) observed in the younger adults.
The difference may reflect the stigma attached to epilepsy 11 and subsequent denial and unwillingness to seek medical treatment, particularly by older patients or parents. The lower difference in the 25-34 age group may be due to young adults becoming confident enough to seek treatment for employment or social reasons. The only previous study looking at stigmatization in Pakistan was unable to establish its importance, but this may have been due to the reliance on an unvalidated, self-reported questionnaire rather than more in-depth qualitative research that may have been required to explore this issue 12 .
The difference may reflect inadequate medical management due to poor communication. Epilepsy is primarily a clinical diagnosis. Where communication is poor between patient and doctor, and the doctor fails to take an adequate history, then the diagnosis may be missed. This again may be more marked in older patients where English is not their first language.
Classification and aetiology
Seizure classification in epidemiological studies is notoriously difficult as recording is often unreliable and EEG confirmation impractical and even in hospital practice around a third of cases are unclassifiable 13 . Previous international studies have found that around half of cases are partial epilepsy and half generalized 4 . In the United Kingdom a previous study in primary care found that 52% of patients had partial seizures, 39% generalized and 9% unclassifiable 14 . The proportion of patients with partial seizures in this study was low (33%). This may reflect the recording and classification biases inherent in the study methodology.
Only 30% of cases of epilepsy had a definite aetiology, a finding backed up by previous international and UK studies 1, 14 . The reliance on general practice records rather than direct review of neuroimaging and EEG results may underestimate the proportion of cases with known causative factors.
Estimating prescribing patterns from market share is complicated by the lack of linkage between prescribing information and diagnosis. Several of the an-ticonvulsant drugs have other prescribing indications. Our data confirm national market share data about the top three drugs being carbamazepine (36% nationally, 34% in Bradford), sodium valproate (24% nationally, 30% in Bradford) and phenytoin (22% nationally, 16% in Bradford) (IMS Health personal communication, 1998 data). Differences may reflect local prescribing trends and improved accuracy of data linked to diagnosis.
CONCLUSIONS
This large population study adds to our knowledge of the prevalence, demography, aetiology and treatment of epilepsy and seizure disorders in the United Kingdom. Previous prevalence and frequency estimates are supported by our results that demonstrate the public health importance of epilepsy. The low prevalence of epilepsy in the South Asian population is a surprising result and one that prompts concern about the equity of service provision. Further research is required into cultural attitudes to epilepsy and the impact of stigma. A high diagnostic index of suspicion for the possibility of epilepsy in South Asian patients may be warranted in view of the potential for missed diagnoses due to poor communication.
